Medical Device Failures: Atlanta Patient’s 2026 Fight

Listen to this article · 9 min listen

In late 2024, Sarah Jenkins, a lively 58-year-old living in Atlanta’s historic Grant Park neighborhood, believed a spinal stimulator would be her salvation from chronic back pain. Two years later, she found herself working through a labyrinth of medical appointments, legal consultations, and debilitating discomfort, a stark illustration of the challenges in upholding consumer rights when medical devices fail. Her experience raises critical questions about product safety and the ethical responsibilities of manufacturers.

Key Takeaways

  • Patients experiencing medical device failure should immediately document all symptoms and communications with healthcare providers and manufacturers.
  • Federal regulations, specifically FDA 510(k) clearance, allow some medical devices to enter the market with less rigorous testing than new products, a factor consumers must understand.
  • Reporting adverse events to the FDA’s MedWatch program is a critical step for individuals to contribute to broader public health monitoring and potential recalls.
  • Consumers have legal avenues, including product liability lawsuits, to seek recourse for injuries caused by defective medical devices.
  • The ethical imperative for medical device manufacturers extends beyond regulatory compliance to include transparent reporting of device performance and long-term patient outcomes.

Sarah’s Ordeal: A Promise Unfulfilled

Sarah, a retired teacher, had endured years of sciatica and neuropathic pain that no conservative treatment seemed to touch. Her neurosurgeon at Emory University Hospital Midtown recommended a spinal cord stimulator, a device designed to deliver mild electrical pulses to block pain signals. “He showed me brochures with smiling people hiking, playing with grandchildren,” Sarah recalled during a recent interview at her home near Zoo Atlanta. “It felt like a miracle was within reach.”

The device, implanted in November 2024, initially offered some relief. However, within six months, Sarah began experiencing intermittent shocks and a burning sensation at the implant site. Her pain, far from being managed, intensified. She contacted her doctor, who initially suggested it might be her body adjusting. But the symptoms persisted, escalating to frequent, sharp pains that radiated down her leg, worse than before the surgery. This wasn’t just discomfort. It was a deep disruption to her life.

Working through the Medical Maze: When Trust Erodes

By late 2025, Sarah’s quality of life had plummeted. She could no longer enjoy her morning walks through Oakland Cemetery or tend to her beloved rose garden. Multiple follow-up appointments revealed no clear mechanical failure according to the device manufacturer’s diagnostics, yet her symptoms were undeniable. This often happens. Patients are left feeling dismissed, their subjective experience clashing with objective tests. “They kept saying the device was ‘functioning within parameters’,” Sarah explained, her voice tinged with frustration. “But my body was screaming otherwise.”

This disconnect highlights a significant challenge in medical ethics. Physicians are often reliant on manufacturer data and training, which may not fully capture the spectrum of real-world patient experiences or subtle device malfunctions. The onus then falls on the patient to advocate fiercely for themselves, often while in significant pain. I’ve seen this pattern repeatedly in my practice. Patients become medical detectives, trying to piece together what’s happening to them.

The Regulatory Field: A Patchwork of Protection

Spinal stimulators, like many other medical devices, typically gain market approval through the U.S. Food and Drug Administration’s (FDA) 510(k) clearance process. This pathway allows devices to be marketed if they are “substantially equivalent” to a legally marketed predicate device, often requiring less rigorous clinical testing than premarket approval (PMA) for novel devices. While efficient, critics argue this can leave gaps in understanding long-term performance and potential complications. According to a 2023 report from the Government Accountability Office (GAO), the FDA cleared over 3,000 devices via the 510(k) pathway in 2022 alone, with a significant portion being high-risk devices like implants. This speed has trade-offs. You have to wonder if the pace of innovation sometimes outstrips the thoroughness of evaluation.

Sarah’s attorney, Michael Chen, a product liability specialist with Chen & Associates in downtown Atlanta, pointed out the complexities. “Manufacturers have a duty to ensure their products are safe and effective,” Chen stated. “However, proving a specific defect in a device cleared through the 510(k) process can be challenging, as the bar for initial approval is lower.” He emphasized the importance of documenting every symptom, every doctor’s visit, and every communication with the manufacturer. This careful record-keeping becomes the backbone of any potential legal claim, protecting consumer rights.

The Ethical Imperative: Beyond Compliance

The ethical obligations of medical device manufacturers extend beyond mere regulatory compliance. There’s a moral duty to prioritize patient well-being, which includes transparent reporting of adverse events, ongoing post-market surveillance, and prompt investigation into patient complaints. When a device fails, the human cost is immense. It’s not just a product recall. It’s a life disrupted, often permanently.

In Sarah’s case, the manufacturer conducted remote diagnostics and eventually offered a device replacement, but only after months of persistent complaints and a second opinion from a specialist at Piedmont Atlanta Hospital who noted subtle, intermittent signal irregularities. The replacement surgery in March 2026 was successful in resolving the shocks, but the underlying neuropathic pain remained, now compounded by surgical trauma. “It felt like they were doing the bare minimum,” Sarah reflected. “No real apology, just a technical solution to a technical problem, ignoring the months of suffering.”

This experience shows the need for strong systems that capture patient-reported outcomes (PROs) more effectively. Standardized PRO measures could provide invaluable data on device performance in real-world settings, offering a more complete picture than clinical trials alone. The FDA’s MedWatch program allows individuals to report adverse events, creating a public database that can signal potential widespread issues. Sarah’s legal team encouraged her to file a detailed MedWatch report, contributing to a larger dataset that might flag systemic problems with the device model she received. This is an important step many patients overlook.

Seeking Redress: Legal Avenues for Consumers

For individuals like Sarah, legal recourse often involves product liability claims. These claims typically fall into three categories: manufacturing defects (the device was improperly made), design defects (the inherent design is unsafe), or failure to warn (inadequate instructions or warnings about risks). Proving these can be complex, requiring expert testimony and extensive discovery into a manufacturer’s internal documents.

In Georgia, product liability cases are governed by statutes such as O.C.G.A. Section 51-1-11, which outlines liability for manufacturers of personal property sold for use. Chen’s firm has begun exploring a potential claim against the device manufacturer, focusing on whether the device’s design contributed to the intermittent malfunctions Sarah experienced, or if there was an inadequate warning regarding the potential for such severe, non-diagnosticable symptoms. “The goal isn’t just compensation,” Chen explained. “It’s about holding companies accountable and pushing for safer products for everyone.”

The legal process can be lengthy and emotionally draining, often taking years to resolve. For Sarah, the prospect of a protracted legal battle is daunting, but she feels a responsibility. “If my story can prevent just one other person from going through this, it’s worth it,” she said, her voice firm. Her journey highlights that while medical technology offers incredible promise, it also carries significant risks that demand vigilant oversight and unwavering commitment to product safety.

The resolution for Sarah is still unfolding. While the replacement device has eliminated the shocks, her chronic pain persists, and she now attends physical therapy three times a week at the Shepherd Center in Buckhead. She has become an advocate, sharing her story with local patient groups and urging others to research medical devices thoroughly and to question everything. Her journey highlights that when medical devices fail, it’s not just a technical glitch. It’s a deep breach of trust and a significant challenge to individual well-being, demanding a strong response from both regulatory bodies and the legal system.

When facing a medical device failure, immediate, detailed documentation of symptoms, medical consultations, and communications with manufacturers is paramount for protecting your rights and contributing to broader safety improvements.

What should I do immediately if I suspect my spinal stimulator is failing?

Document all new or worsening symptoms, including dates, times, and severity. Contact your implanting physician immediately to report the issues and schedule an evaluation. Keep detailed records of all communications with your doctor and the device manufacturer.

How does the FDA’s 510(k) clearance process affect medical device safety?

The 510(k) process allows devices to be marketed if they are “substantially equivalent” to an existing device, often requiring less extensive clinical trials than novel devices. While efficient, this pathway can sometimes mean that long-term complications or rare adverse events may not be fully understood until after the device is widely used.

Can I report a problem with my medical device directly to the FDA?

Yes, you can report adverse events or quality problems with medical devices directly to the FDA through their MedWatch program. This information is important for the FDA to monitor device safety and identify potential widespread issues that may warrant further investigation or recalls.

What kind of legal options do I have if I’m injured by a defective spinal stimulator?

You may have grounds for a product liability lawsuit against the device manufacturer. These cases typically allege manufacturing defects, design defects, or a failure to warn about potential risks. Consulting with an attorney specializing in medical device litigation is advisable to understand your specific legal options.

What ethical responsibilities do medical device manufacturers have beyond regulatory compliance?

Ethical responsibilities include transparently reporting all known risks and adverse events, conducting thorough post-market surveillance, promptly investigating patient complaints, and prioritizing patient safety over commercial interests. This also involves clear communication with healthcare providers and patients about device performance and potential complications.

Chelsea Lee

Senior Policy Analyst MPP, Georgetown University

Chelsea Lee is a Senior Policy Analyst with fifteen years of experience dissecting complex regulatory frameworks for news organizations. Specializing in technology policy and its societal impact, she has served as a lead analyst for the Digital Rights Initiative and a contributing editor at PolicyWatch Global. Her work frequently uncovers the unseen implications of emerging legislation, earning her a commendation for her groundbreaking report, 'Algorithmic Accountability: A New Frontier in Public Oversight.'